Medicare Rx medication therapy management
Executive Summary
Centers for Medicare & Medicaid Services sets 2006 "cost threshold" for Medicare beneficiaries targeted for medication therapy management services under Part D benefit. Patient drug spending must be "likely to exceed" $4,000 a year for multiple chronic diseases. Overall, CMS is giving Medicare drug plans free rein in implementing required medication therapy management programs (1"The Pink Sheet" Feb. 7, 2005, p. 21)...
You may also be interested in...
Medication Therapy Management Standards Will Be Set In Practice, Not Regs
The Centers for Medicare & Medicaid Services will give Part D plans free rein in implementing required medication therapy management programs
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.